Copyright © 2004 by the European Society of Cardiology.
Letter to the Editor
Screening for cardiovascular disease
Department of Chemical Pathology, St. Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK
The Ipswich Hospital, Ipswich, Suffolk IP4 5PD, UK
Queen's Hospital, Burton-on-Trent, Staffordshire DE13 0RB, UK
* Corresponding author. Tel.: +44-2079289292x2027; Fax: +44-2079284226
E-mail address: anthony.wierzbicki@kcl.ac.uk
| The first 10% of the full text of this article appears below. |
Sir,
The paper by Empana et al.1 reviewing the utility of the Framingham and PROCAM cardiovascular risk calculation algorithms in a validation study against the PRIME cohort raises many issues. Firstly definitions are of critical importance for defining categorical variables.2 The definitions of diabetes and family history have either changed